United States · FDA National Drug Code directory
bisoprolol fumarate and hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-3241_26f2531b-2b5e-46a5-9a31-fa7cd89ef8b2
- Product NDC
- 0093-3241
- Form
- TABLET, FILM COATED
- Composition / generic term
- bisoprolol fumarate and hydrochlorothiazide
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20190807
- Source listing expiry
- 20271231
Source-listed ingredients
- BISOPROLOL FUMARATE — 2.5 mg/1
- HYDROCHLOROTHIAZIDE — 6.25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (0093-3241-01) · 0093-3241-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →